Fig. 4.
Isoflurane modulates sub-threshold transient and persistent currents. (A) Representative currents recorded by a stair ramp protocol. Transient (INaT) and state-steady persistent (INaP) currents at each potential were calculated. (B) Sample of initial part of recording. INaT was inhibited by isoflurane at a clinically relevant concentration (0.42 mM, ~1.6 minimum alveolar concentration [MAC], n = 8, P = 0.047, and P = 0.011) at potentials of −50 and −45 mV (C), whereas INaP was inhibited at a potential of −60 mV (D, n = 9, P = 0.044). Data are mean ± SD. *P < 0.05 by two-way ANOVA. CTL, control; ISO, isoflurane.

Isoflurane modulates sub-threshold transient and persistent currents. (A) Representative currents recorded by a stair ramp protocol. Transient (INaT) and state-steady persistent (INaP) currents at each potential were calculated. (B) Sample of initial part of recording. INaT was inhibited by isoflurane at a clinically relevant concentration (0.42 mM, ~1.6 minimum alveolar concentration [MAC], n = 8, P = 0.047, and P = 0.011) at potentials of −50 and −45 mV (C), whereas INaP was inhibited at a potential of −60 mV (D, n = 9, P = 0.044). Data are mean ± SD. *P < 0.05 by two-way ANOVA. CTL, control; ISO, isoflurane.

Close Modal

or Create an Account

Close Modal
Close Modal